Pharmacotherapy of anxiety disorders: which substances are declared as first choice treatment options by Polish psychiatrists?

Psychiatria Spersonalizowana Pub Date : 2023-01-01 DOI:10.5114/psychs.2023.125705

Sławomir Murawiec, Natalia Olejnik, Agata Kudlik

{"title":"Pharmacotherapy of anxiety disorders: which substances are declared as first choice treatment options by Polish psychiatrists?","authors":"Sławomir Murawiec, Natalia Olejnik, Agata Kudlik","doi":"10.5114/psychs.2023.125705","DOIUrl":null,"url":null,"abstract":"AMA Murawiec S, Olejnik N, Kudlik A. Pharmacotherapy of anxiety disorders: which substances are declared as first choice treatment options by Polish psychiatrists?. Psychiatria Spersonalizowana. 2023;2(1):7-15. doi:10.5114/psychs.2023.125705. APA Murawiec, S., Olejnik, N., & Kudlik, A. (2023). Pharmacotherapy of anxiety disorders: which substances are declared as first choice treatment options by Polish psychiatrists?. Psychiatria Spersonalizowana, 2(1), 7-15. https://doi.org/10.5114/psychs.2023.125705 Chicago Murawiec, Sławomir, Natalia Olejnik, and Agata Kudlik. 2023. \"Pharmacotherapy of anxiety disorders: which substances are declared as first choice treatment options by Polish psychiatrists?\". Psychiatria Spersonalizowana 2 (1): 7-15. doi:10.5114/psychs.2023.125705. Harvard Murawiec, S., Olejnik, N., and Kudlik, A. (2023). Pharmacotherapy of anxiety disorders: which substances are declared as first choice treatment options by Polish psychiatrists?. Psychiatria Spersonalizowana, 2(1), pp.7-15. https://doi.org/10.5114/psychs.2023.125705 MLA Murawiec, Sławomir et al. \"Pharmacotherapy of anxiety disorders: which substances are declared as first choice treatment options by Polish psychiatrists?.\" Psychiatria Spersonalizowana, vol. 2, no. 1, 2023, pp. 7-15. doi:10.5114/psychs.2023.125705. Vancouver Murawiec S, Olejnik N, Kudlik A. Pharmacotherapy of anxiety disorders: which substances are declared as first choice treatment options by Polish psychiatrists?. Psychiatria Spersonalizowana. 2023;2(1):7-15. doi:10.5114/psychs.2023.125705.","PeriodicalId":500880,"journal":{"name":"Psychiatria Spersonalizowana","volume":"11 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychiatria Spersonalizowana","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/psychs.2023.125705","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

AMA Murawiec S, Olejnik N, Kudlik A. Pharmacotherapy of anxiety disorders: which substances are declared as first choice treatment options by Polish psychiatrists?. Psychiatria Spersonalizowana. 2023;2(1):7-15. doi:10.5114/psychs.2023.125705. APA Murawiec, S., Olejnik, N., & Kudlik, A. (2023). Pharmacotherapy of anxiety disorders: which substances are declared as first choice treatment options by Polish psychiatrists?. Psychiatria Spersonalizowana, 2(1), 7-15. https://doi.org/10.5114/psychs.2023.125705 Chicago Murawiec, Sławomir, Natalia Olejnik, and Agata Kudlik. 2023. "Pharmacotherapy of anxiety disorders: which substances are declared as first choice treatment options by Polish psychiatrists?". Psychiatria Spersonalizowana 2 (1): 7-15. doi:10.5114/psychs.2023.125705. Harvard Murawiec, S., Olejnik, N., and Kudlik, A. (2023). Pharmacotherapy of anxiety disorders: which substances are declared as first choice treatment options by Polish psychiatrists?. Psychiatria Spersonalizowana, 2(1), pp.7-15. https://doi.org/10.5114/psychs.2023.125705 MLA Murawiec, Sławomir et al. "Pharmacotherapy of anxiety disorders: which substances are declared as first choice treatment options by Polish psychiatrists?." Psychiatria Spersonalizowana, vol. 2, no. 1, 2023, pp. 7-15. doi:10.5114/psychs.2023.125705. Vancouver Murawiec S, Olejnik N, Kudlik A. Pharmacotherapy of anxiety disorders: which substances are declared as first choice treatment options by Polish psychiatrists?. Psychiatria Spersonalizowana. 2023;2(1):7-15. doi:10.5114/psychs.2023.125705.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

焦虑症的药物治疗:波兰精神病学家宣布哪些物质是首选治疗方案?

A.焦虑障碍的药物治疗:波兰精神科医生宣布哪些物质是首选治疗方案?精神病学杂志，2009;2(1):7-15。doi: 10.5114 / psychs.2023.125705。APA Murawiec, S, Olejnik, N， & Kudlik, A.(2023)。焦虑症的药物治疗:波兰精神病学家宣布哪些物质是首选治疗方案?精神病学杂志，2(1)，7-15。https://doi.org/10.5114/psychs.2023.125705 Chicago Murawiec, Sławomir, Natalia Olejnik和Agata Kudlik。2023。焦虑症的药物治疗:波兰精神病学家宣布哪些物质是首选治疗方案?精神病学杂志2(1):7-15。doi: 10.5114 / psychs.2023.125705。Harvard Murawiec, S, Olejnik, N.和Kudlik, A.(2023)。焦虑症的药物治疗:波兰精神病学家宣布哪些物质是首选治疗方案?精神病学杂志，2(1)，pp.7-15。https://doi.org/10.5114/psychs.2023.125705 MLA Murawiec, Sławomir等。焦虑症的药物治疗:波兰精神病学家宣布哪些物质是首选治疗方案?精神病学，第二卷，第2期。1, 2023，第7-15页。doi: 10.5114 / psychs.2023.125705。王晓明，王晓明。焦虑障碍的药物治疗:波兰精神病学家宣布哪些药物是首选治疗方案?精神病学杂志，2009;2(1):7-15。doi: 10.5114 / psychs.2023.125705。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Psychiatria Spersonalizowana

自引率

0.00%

发文量

期刊最新文献

Alprazolam – a simple guide in questions and answers Aripiprazole ODT – who is this alternative for? A simple guide in questions and answers Paranoid schizophrenia – gender differences in the course of the disease Pharmacotherapy in women with schizophrenia Personalized psychopharmacology in integrated medical model